Market revenue in 2023 | USD 49.0 million |
Market revenue in 2030 | USD 61.7 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.37% in 2023. Horizon Databook has segmented the Germany in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the major markets in Europe, owing to its established clinical diagnostics industry, increasing R&D activities to develop novel testing methods, and high prevalence of chronic diseases, such as cancer & diabetes.
For instance, according to GLOBOCAN, in 2022, the prevalence of cancer was 1.88 million, and around 605,805 new cases of cancer were diagnosed in Germany. Increasing awareness among people about early diagnosis and stringent regulations related to the safety and accuracy of diagnostic tests are anticipated to drive the demand for IVD quality control in the country.
Moreover, a strong presence of key players, including Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Merck KGaA; and Qiagen, among others, and continuous strategic initiatives being undertaken by them are anticipated to support market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Germany in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account